Skip to Content

54 107 (Lithium Carbonate Extended Release 300 mg)

Pill with imprint 54 107 is Beige, Round and has been identified as Lithium Carbonate Extended Release 300 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 107

Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release 300 mg 54 107  Front
Lithium carbonate extended release 300 mg 54 107  Back
Lithium carbonate extended release 300 mg 54 107

Lithium Carbonate Extended Release

Imprint
54 107
Strength
300 mg
Color
Beige
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roxane Laboratories, Inc.
Inactive Ingredients
calcium stearate, povidone, sodium chloride, sodium lauryl sulfate, sorbitol, hypromelloses, polydextrose, ferric oxide red, titanium dioxide, triacetin, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00054-0021 Roxane Laboratories, Inc.
68084-0640 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.